Mwyngil Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Mwyngil Therapeutics General Information

Description

Developer of targeted treatments intended for cancer, immunological and neurodegenerative diseases. The company is currently operating in Stealth Mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 12760 High Bluff Drive
  • Suite 370
  • San Diego, CA 92130
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 12760 High Bluff Drive
  • Suite 370
  • San Diego, CA 92130
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mwyngil Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-May-2022 Completed Stealth
To view Mwyngil Therapeutics’s complete valuation and funding history, request access »

Mwyngil Therapeutics Patents

Mwyngil Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024211236-A1 Inhibitors of nlrp3 Pending 27-Jan-2023
AU-2026257528-A1 Inhibitors of nlrp3 Pending 27-Jan-2023
EP-4655287-A2 Inhibitors of nlrp3 Pending 27-Jan-2023
US-20260234123-A1 Inhibitors of nlrp3 Pending 27-Jan-2023
WO-2024158941-A2 Inhibitors of nlrp3 Inactive 27-Jan-2023 C07D401/12
To view Mwyngil Therapeutics’s complete patent history, request access »

Mwyngil Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
i2020 Accelerator Accelerator/Incubator Minority
To view Mwyngil Therapeutics’s complete investors history, request access »

Mwyngil Therapeutics FAQs

  • Where is Mwyngil Therapeutics headquartered?

    Mwyngil Therapeutics is headquartered in San Diego, CA.

  • What industry is Mwyngil Therapeutics in?

    Mwyngil Therapeutics’s primary industry is Drug Discovery.

  • Is Mwyngil Therapeutics a private or public company?

    Mwyngil Therapeutics is a Private company.

  • What is Mwyngil Therapeutics’s current revenue?

    The current revenue for Mwyngil Therapeutics is .

  • Who are Mwyngil Therapeutics’s investors?

    i2020 Accelerator has invested in Mwyngil Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process